Peptide Laws in Algeria
DZ · Africa · 23 peptides tracked
Are Peptides Legal in Algeria?
Algeria has the largest pharmaceutical market in francophone Africa with moderate enforcement and import restrictions. Importing research peptides without authorization could result in seizure at customs. There is no domestic peptide vendor market, and prescription peptides are available through the formal healthcare system. Travelers should expect more customs scrutiny here than in most African countries.
4
Legal18
Grey Area1
PrescriptionCan You Buy Peptides in Algeria?
4 peptide(s) are legal to buy in Algeria, including GHK-Cu, NAD+, Glutathione, Vitamin B12. 1 peptide(s) require a valid prescription, including Semaglutide. 18 peptide(s) fall into a legal grey area: Tirzepatide, Selank, MOTS-c, TB-500, Ipamorelin, and 13 more. These may be available for research purposes but their legality for personal use is ambiguous.
Traveling to Algeria with Peptides
When traveling to Algeria with peptides, the legality depends on each peptide's classification. Prescription peptides (Semaglutide) typically require documentation such as a prescription or doctor's letter when crossing borders. Enforcement in Algeria is rated as "Moderate." Always declare pharmaceutical products at customs and carry documentation of any prescriptions.
New to peptides? Start with the basics on peptide.camp →
Need to source peptides for Algeria? Get verified wholesale quotes on peptide.broker →
Traveling to Algeria with peptides? TSA tips, packing guides & the peptide travel case on peptide.travel →
Peptide Regulations in Algeria
| Peptide | Status | Rx Required | Schedule | Detail | Source |
|---|---|---|---|---|---|
| Tirzepatide | Grey Area | Yes | Not Registered | Not ANPP registered. Would require registration and prescription under Art. 179 if approved. | Secondary |
| Selank | Grey Area | No | Unregistered | Russian nootropic. Not ANPP registered. Import restrictions likely prevent access. | Secondary |
| MOTS-c | Grey Area | No | Unregistered | Novel peptide. Not ANPP registered. Import restrictions apply. | Secondary |
| TB-500 | Grey Area | No | Unregistered | Same as BPC-157. Not ANPP registered. Import requires drugs to be marketed in country of origin + third country first. | Secondary |
| GHK-Cu | Legal | No | Cosmetic | Topical cosmetic use unrestricted. Injectable form requires ANPP registration. | Secondary |
| Ipamorelin | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. Import restrictions apply. | Secondary |
| Semaglutide | Prescription | Yes | Prescription Only | Prescription medicine per Art. 179 of Law 18-11. ANPP registration required. Pharmacists cannot dispense without prescription. Import licensing through DGPES. Algeria has significant local pharmaceutical manufacturing capacity. | Secondary |
| CJC-1295 | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. Import restrictions effectively prevent access — must be marketed in origin + third country first. | Secondary |
| Semax | Grey Area | No | Unregistered | Russian nootropic. Not ANPP registered. Import restrictions likely prevent access. | Secondary |
| BPC-157 | Grey Area | No | Unregistered | Not ANPP registered. Art. 179 of Law 18-11 prohibits dispensing without prescription. ANPP (est. 2018 under Art. 223) regulates all pharmaceutical products. Serialization mandatory per 2025 decree (Arrêté N°25). Drug import requires prior marketing in country of origin + third country. | Secondary |
| NAD+ | Legal | No | Supplement | NAD+ supplements not classified as medicines under Law 18-11. Available through import. OTC classification possible for supplements with proven safety. | Secondary |
| Retatrutide | Grey Area | No | Unregistered | Investigational compound. Not ANPP registered. Cannot meet import requirement of prior marketing in country of origin. | Secondary |
| AOD-9604 | Grey Area | No | Unregistered | Not specifically regulated. GH fragment not addressed. Import restrictions apply. | Secondary |
| Glutathione | Legal | No | Supplement | — | Unsourced |
| DSIP | Grey Area | No | Unregistered | — | Unsourced |
| Epithalon | Grey Area | No | Unregistered | — | Unsourced |
| KPV | Grey Area | No | Unregistered | — | Unsourced |
| HGH | Grey Area | No | Unregistered | — | Unsourced |
| Liraglutide | Grey Area | No | Unregistered | — | Unsourced |
| Melanotan II | Grey Area | No | Unregistered | — | Unsourced |
| MK-677 | Grey Area | No | Unregistered | — | Unsourced |
| Vitamin B12 | Legal | No | Supplement | — | Unsourced |
| PT-141 | Grey Area | No | Unregistered | — | Unsourced |
About the sources on this page
Entries marked Official cite a government regulator, legislation or an official gazette. Entries marked Secondary rest on consultancy, law firm, news or academic reporting rather than the regulator itself. Some entries currently carry no source at all.
We show these entries rather than hiding them, but they should not be relied on. Nothing on this site is legal advice. Verify against the national regulator before acting, and if you can point us at a better source please submit an update.
Data is researcher-verified but not legal advice. Always consult local regulations before purchasing, importing, or traveling with peptides. Last verified: 2026-02-28.